Stockreport

NeoPhore raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline [Yahoo! Finance]

INTESA SANPAOLO S/ADR  (ISNPY) 
PDF LONDON Feb. 1, 2024 /PRNewswire/ -- NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announces a further extension of £9.6m (approx. USD $12 [Read more]